Literature DB >> 12940436

Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease.

W Klein1, A Tromm, T Griga, C Folwaczny, M Hocke, K Eitner, M Marx, N Duerig, J T Epplen.   

Abstract

BACKGROUND: Associations of variations in the CARD15 gene (Arg702Trp, Gly908Arg and Leu1007fsinsC) and Crohn disease (CD) have been shown recently. These variations are neither necessary nor sufficient for the genetic predisposition of CD. Further genetic and environmental factors play a crucial role in the pathogenesis of CD.
METHODS: To evaluate putative interactions between the CARD15 and CD14 genes in CD, a functionally relevant polymorphism in the promoter region (T/C at position -159) has been genotyped for 650 healthy controls and 253 patients with CD by RFLP analyses. CD patients were genotyped for the variations of the CARD15 gene.
RESULTS: T allele and TT genotype frequencies of the CD14 promoter were significantly increased only in CD patients with at least one variation in the CARD15 gene compared to controls (P = 0.02 and 0.0002, respectively). No significant association was found in CD patients without any of the variations.
CONCLUSION: Interactions of the CARD15 and CD14 genes, both of which are involved in the recognition of lipopolysaccharides, increase the risk for developing CD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12940436     DOI: 10.1080/00365520310003147

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.

Authors:  Maria Gazouli; Gerassimos Mantzaris; Athanassios Kotsinas; Panayotis Zacharatos; Efstathios Papalambros; Athanassios Archimandritis; John Ikonomopoulos; Vassilis-G Gorgoulis
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

2.  Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.

Authors:  H-P Török; J Glas; L Tonenchi; P Lohse; B Müller-Myhsok; O Limbersky; C Neugebauer; F Schnitzler; J Seiderer; C Tillack; S Brand; G Brünnler; P Jagiello; J T Epplen; T Griga; W Klein; U Schiemann; M Folwaczny; T Ochsenkühn; C Folwaczny
Journal:  Gut       Date:  2005-06-14       Impact factor: 23.059

3.  No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis.

Authors:  M van der Paardt; J B A Crusius; M H M T de Koning; S A Morré; R J van de Stadt; B A C Dijkmans; A S Peña; I E van der Horst-Bruinsma
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

4.  CARD15/NOD2, CD14 and toll-like 4 receptor gene polymorphisms in Saudi patients with Crohn's Disease.

Authors:  Nahla Azzam; Howaida Nounou; Othman Alharbi; Abedulrahman Aljebreen; Manal Shalaby
Journal:  Int J Mol Sci       Date:  2012-04-02       Impact factor: 6.208

5.  On the genetic involvement of apoptosis-related genes in Crohn's disease as revealed by an extended association screen using 245 markers: no evidence for new predisposing factors.

Authors:  Sonja E N Wagenleiter; Peter Jagiello; Denis A Akkad; Larissa Arning; Thomas Griga; Wolfram Klein; Jörg T Epplen
Journal:  J Negat Results Biomed       Date:  2005-11-30

6.  The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology.

Authors:  Sander Ouburg; Joke Spaargaren; Janneke E den Hartog; Jolande A Land; Johan S A Fennema; Jolein Pleijster; A Salvador Peña; Servaas A Morré
Journal:  BMC Infect Dis       Date:  2005-12-20       Impact factor: 3.090

7.  Association between CD14 gene C-260T polymorphism and inflammatory bowel disease: a meta-analysis.

Authors:  Zhengting Wang; Jiajia Hu; Rong Fan; Jie Zhou; Jie Zhong
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.